Product and method for treating diarrhea
AssigneeMaregade Rx, LLC
InventorReed B. Hogan, II
Life of this patent
Estimating the term…
Abstract
A method of treating diarrhea in a patient includes administering an H1 receptor antagonist and an H2 receptor antagonist to the patient.
Claims26
A method of treating diarrhea in a patient, comprising administering an H1 receptor antagonist and an H2 receptor antagonist to the patient, wherein the patient does not have mastocytic enterocolitis.
A method of treating diarrhea in a patient, comprising administering an H1 receptor antagonist and an H2 receptor antagonist to the patient, wherein the H1 receptor antagonist comprises cetirizine and the H2 receptor antagonist comprises famotidine.
A method of treating diarrhea in a patient, comprising administering an H1 receptor antagonist and an H2 receptor antagonist to the patient, wherein the H2 receptor antagonist is not ranitidine.
22-40. (canceled)
A pharmaceutical composition for treating diarrhea, comprising:
- an H1 receptor antagonist, and
- an H2 receptor antagonist,
- wherein the H2 receptor antagonist is not ranitidine, and
- the pharmaceutical composition is an oral dosage form.
42-50. (canceled)
A pharmaceutical composition for treating diarrhea, comprising:
- an H1 receptor antagonist, and
- an H2 receptor antagonist,
- wherein the H1 receptor antagonist is not diphenhydramine.
52-80. (canceled)
Dependencies are inferred from the claim text.